Examining a Text Message Intervention for Smoking Cessation
- Conditions
- Tobacco Use DisorderNicotine Dependence
- Interventions
- Behavioral: text messaging for smoking cessationBehavioral: Generic text messages
- Registration Number
- NCT01166464
- Lead Sponsor
- The Miriam Hospital
- Brief Summary
The primary goal of this study is to use qualitative interviews and focus groups to aid us in adapting a face-to-face smoking cessation intervention for delivery through text messaging. After design is completed, the intervention will be pilot tested with a sample of young adults (ages 18-35) who smoke. Final assessments will be conducted at 7 weeks (end of treatment) and both 3 and 6 month follow up.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 84
- Age 18 to 35
- Current daily smoker
- Has a cell phone with text messaging capability
- Uses text messaging at least once monthly
- Interested in quitting smoking
- Willing to set a quit date within the next 30 days
- Has access to a physician
- Does not read and speak English with adequate comprehension
- Is currently participating in a smoking cessation program
- Concurrent drug/alcohol abuse
- Mental health issues that would interfere with study compliance
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Text Messaging text messaging for smoking cessation A text message-based intervention for smoking cessation Control Generic text messages Individuals in this group will receive generic (non-smoking related) text messages on the same schedule as the intervention arm. This provides a control for staff/program contact time and participant burden.
- Primary Outcome Measures
Name Time Method Smoking abstinence Six months post-treatment 7-day point prevalence abstinence will be measured at 6 months post-treatment.
- Secondary Outcome Measures
Name Time Method Usability and Acceptability of the intervention 7 weeks (end of treatment) Usability and acceptability of the intervention will be assessed at the end of treatment (week 7).
Trial Locations
- Locations (1)
The Miriam Hospital
🇺🇸Providence, Rhode Island, United States